On-Demand Webinars

  1. Unlocking Hidden Efficiencies In Cell And Gene Therapy Manufacturing 10/28/2026

    Identify hidden bottlenecks, cut batch variability, reduce costs, and protect quality. Learn strategies to streamline GMP transitions and speed commercialization.

  2. Scaling Spray-dried Dispersions For Commercial Success: Scale, Capacity, Supply 10/26/2026

    Scaling SDDs takes more than larger batches. Explore how early planning and process understanding can preserve performance and reduce commercialization risk.

  3. Bioconjugation Scale-Up: Data-Driven Strategies From 10 L To 500 L 10/23/2026

    Data-driven scale-up of ADC bioconjugation depends on matching mixing and temperature conditions. Solvent compatibility of single-use components and production-scale economics round out the decisions.

  4. Plastic Components And Systems Used In Pharmaceutical Manufacturing 10/23/2026

    Ensuring regulatory compliance for manufacturing components requires rigorous chemical characterization and risk-based testing to safeguard patient safety and product quality.

  5. Viral Vector for Rare and Ultra-rare Disease 10/20/2026
  6. Building a Global Manufacturing Network: "Dual-Sourcing" Commercial Strategies 10/19/2026

    EU entry after FDA approval puts launch timing and supply continuity at risk. QP release, importation pathways, and distributed manufacturing networks all shape whether a biologic reaches the market predictably.

  7. Linking Biomarkers To Clinical Proof-Of-Mechanism 10/19/2026

    Proving CNS delivery and target engagement in neurodegenerative therapies requires aligned clinical pharmacology and bioanalysis, from model selection to validated assays.

  8. Precision At Scale: Optimizing Cell-Free DNA Manufacturing For mRNA Vaccines 10/16/2026

    Backbone-free enzymatic DNA templates can improve polyA integrity, long-transcript quality, and RNA yield, with implications for IVT timelines and regulation.

  9. Science-Driven Risk Mitigation In Single-Use Drug Product Processing 10/16/2026

    Explore how extractables and leachables from single-use systems can affect peptide stability, as well as how science-led approaches to component selection can reduce risk throughout manufacturing.

  10. The Critical Role Of Excipients In GLP-1 Agonist Formulation Design 10/16/2026

    Excipient selection shapes GLP-1 agonist formulations, from granulated buffers to carrier-based systems aimed at improving solubility and achieving targeted release in the intestine.